Profile

Nicholas Alexander Vitanza, MD

Nicholas Alexander Vitanza, MD

Hematology-Oncology

On staff since August 2016

Academic Title: Acting Assistant Professor

  • Award Name Award Description Awarded By Award Date
    Outstanding Research Commendation International Society of Pediatric Neuro-Oncology Conference, Liverpool, UK 2016
    Outstanding Research Award Stanford University, 7th Annual Stanford Pediatric Research Retreat 2016
    Young Investigator Award American Society of Pediatric Hematology/Oncology 2014
    Research Training Award for Fellows (RTAF) American Society of Hematology 2013
    Frances Pope Memorial Foundation Fellow New York University Langone Medical Center 2012
    Resident Researcher of the Year Award Stony Brook University 2011
    Resident Teacher of the Year Award Stony Brook University 2009
    • Vitanza NA
      50 Years Ago in TheJournal ofPediatrics: Induction of Remission in Acute Leukemia of Childhood by Combination of Prednisone and Either 6-Mercaptopurine or Methotrexate.
      27234282 The Journal of pediatrics , 2016 June - 2016 June : 173100
    • Vitanza NA, Shaw TM, Gardner SL, Allen JC, Harter DH, Karajannis MA
      Noncarboplatin-induced Sensorineural Hearing Loss in a Patient With an Intracranial Nongerminomatous Germ Cell Tumor
      23652864 : 38(4)312-6
    • Vitanza NA, Cho YJ
      Advances in the biology and treatment of pediatric central nervous system tumors.
      26709691 Current opinion in pediatrics , 2016 Feb. - 2016 Feb. : 28(1)34-9
    • Vitanza NA, Partap S
      Pediatric Ependymoma.
      26503805 J Child Neurol , 2015 Oct. 26
    • Vitanza NA, Hogan LE, Zhang G, Parker RI
      The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia
      25222061 J Pediatr Hematol Oncol , 2015 July : 37(5)356-61
    • Vitanza NA
      50 Years Ago in The Journal of Pediatrics: A Long-Term Study of Cerebrospinal Leukemia.
      26117636 J Pediatr , 2015 July : 167(1)80
    • Vitanza NA, Zaky W, Blum R, Meyer JA, Wang J, Bhatla T, Morrison DJ, Raetz EA, Carroll WL
      Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance
      24976218 Pediatr Blood Cancer , 2014 Oct. : 61(10)1779-85.
    • Bhatla T, Jones CL, Meyer JA, Vitanza NA, Raetz EA, Carroll WL
      The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions
      24942023 : 36(6)413-8.

Overview

Board Certification(s)

Pediatrics
Pediatric Hematology-Oncology

Medical/Professional School

American University of the Caribbean, St. Maarten

Residency

Pediatrics, Stony Brook School of Medicine, Stony Brook

Fellowship

Pediatric Hematology-Oncology, NYU Langone Medical Center, New York
Pediatric Neuro-Oncology, Stanford University, Palo Alto

Clinical Interests

Brain and spinal cord tumors of childhood

Research Description

My basic science research has aimed to evaluate new, targeted drugs against pediatric cancers, including the use of combined molecularly-targeted agents against diffuse intrinsic pontine glioma (DIPG). My focus is to translate this work into new treatment options for children with brain and spinal cord tumors.